Cliniphar Ltd. (TYO:432A)

Cliniphar Statistics

Total Valuation

Cliniphar has a market cap or net worth of JPY 1.45 billion. The enterprise value is 1.38 billion.

Market Cap	1.45B
Enterprise Value	1.38B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Cliniphar has 1.00 million shares outstanding.

Current Share Class	1.00M
Shares Outstanding	1.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 9.01.

PE Ratio	9.01
Forward PE	n/a
PS Ratio	0.39
PB Ratio	1.17
P/TBV Ratio	1.23
P/FCF Ratio	5.39
P/OCF Ratio	5.20
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.28, with an EV/FCF ratio of 5.11.

EV / Earnings	8.54
EV / Sales	0.37
EV / EBITDA	8.28
EV / EBIT	10.26
EV / FCF	5.11

Financial Position

The company has a current ratio of 2.15, with a Debt / Equity ratio of 0.83.

Current Ratio	2.15
Quick Ratio	1.74
Debt / Equity	0.83
Debt / EBITDA	6.23
Debt / FCF	3.85
Interest Coverage	16.75

Financial Efficiency

Return on equity (ROE) is 14.25% and return on invested capital (ROIC) is 12.59%.

Return on Equity (ROE)	14.25%
Return on Assets (ROA)	3.18%
Return on Invested Capital (ROIC)	12.59%
Return on Capital Employed (ROCE)	7.88%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.41
Inventory Turnover	10.60

Taxes

Income Tax	-14.00M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	150

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cliniphar had revenue of JPY 3.70 billion and earned 161.00 million in profits. Earnings per share was 161.00.

Revenue	3.70B
Gross Profit	643.00M
Operating Income	134.00M
Pretax Income	147.00M
Net Income	161.00M
EBITDA	166.00M
EBIT	134.00M
Earnings Per Share (EPS)	161.00

Balance Sheet

The company has 1.44 billion in cash and 1.04 billion in debt, with a net cash position of 405.00 million or 405.00 per share.

Cash & Cash Equivalents	1.44B
Total Debt	1.04B
Net Cash	405.00M
Net Cash Per Share	405.00
Equity (Book Value)	1.24B
Book Value Per Share	1,244.00
Working Capital	1.03B

Cash Flow

In the last 12 months, operating cash flow was 279.00 million and capital expenditures -10.00 million, giving a free cash flow of 269.00 million.

Operating Cash Flow	279.00M
Capital Expenditures	-10.00M
Depreciation & Amortization	32.00M
Net Borrowing	-379.00M
Free Cash Flow	269.00M
FCF Per Share	269.00

Margins

Gross margin is 17.38%, with operating and profit margins of 3.62% and 4.35%.

Gross Margin	17.38%
Operating Margin	3.62%
Pretax Margin	3.97%
Profit Margin	4.35%
EBITDA Margin	4.49%
EBIT Margin	3.62%
FCF Margin	7.27%

Dividends & Yields

Cliniphar does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	11.10%
FCF Yield	18.55%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cliniphar has an Altman Z-Score of 3.37 and a Piotroski F-Score of 4.

Altman Z-Score	3.37
Piotroski F-Score	4